Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 27;10:317. doi: 10.3389/fimmu.2019.00317

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 Liu, Zhou, Wu, Hu, Yang, Li, Wu, Chen, Chen, Lin, Cui, Fu and Wu.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Comparison of CD3⁺ and CD86⁺ lymphocytes in different treatment groups. (A) Representative images of CD3 IHC in tumor tissues of different treatment groups. (B) Percentage of CD3 positive cells in the primary and secondary tumor. (C) Representative IHC images of CD86 infiltration in the tumor tissue of different treatment groups. (D) Percentage of CD86 positive cells in the primary and secondary tumor. The arrows point the CD3 and Cd86 positive cells in tumor tissues from mice that received different treatments (original magnification × 200). Data are expressed as mean ± SE of 5 mice/group. (^*P < 0.05, ^**P < 0.01, ^***P < 0.001, and NS = not significant).